David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TFCFA
1926
PUT
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $2.16M | ﹤0.01% |
63,900
-110,500
| -63% | -$3.83M |
|
|
LXK
1927
CALL
DELISTED
Lexmark Intl Inc
LXK
| $2.16M | ﹤0.01% |
51,000
-23,300
| -31% | -$959K |
|
1928
PUT
Conagra Brands
CAG
$7.77B
| $2.15M | ﹤0.01% |
75,815
-563,087
| -88% | -$15.5M |
|
|
UTX.PRA
1929
DELISTED
UNITED TECHNOLOGIES CORP CORP UNIT (DE)
UTX.PRA
| $2.15M | ﹤0.01% |
+35,000
| New | +$2.18M |
|
1930
Carter's
CRI
$1.26B
| $2.14M | ﹤0.01% |
23,174
-6,030
| -21% | -$521K |
|
1931
Revvity
RVTY
$14.1B
| $2.14M | ﹤0.01% |
41,894
-76,554
| -65% | -$3.55M |
|
1932
CALL
Automatic Data Processing
ADP
$112B
| $2.14M | ﹤0.01% |
25,000
-2,500
| -9% | -$215K |
|
1933
Vail Resorts
MTN
$5.3B
| $2.14M | ﹤0.01% |
+20,679
| New | +$1.87M |
|
1934
Marcus & Millichap
MMI
$1.22B
| $2.13M | ﹤0.01% |
56,952
+50,660
| +805% | +$1.81M |
|
1935
CALL
Eastman Chemical
EMN
$8.34B
| $2.13M | ﹤0.01% |
30,800
-235,500
| -88% | -$17M |
|
|
UNXL
1936
DELISTED
Uni-Pixel, Inc.
UNXL
| $2.13M | ﹤0.01% |
304,335
+39,645
| +15% | +$234K |
|
|
MJN
1937
DELISTED
Mead Johnson Nutrition Company
MJN
| $2.13M | ﹤0.01% |
21,142
-14,489
| -41% | -$1.46M |
|
1938
Mine Safety
MSA
$7.35B
| $2.12M | ﹤0.01% |
+42,545
| New | +$2.06M |
|
|
IMGN
1939
DELISTED
Immunogen Inc
IMGN
| $2.12M | ﹤0.01% |
237,175
-387,994
| -62% | -$2.81M |
|
|
SGEN
1940
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.12M | ﹤0.01% |
59,980
+31,674
| +112% | +$1.08M |
|
|
NOR
1941
DELISTED
NORANDA ALUM HLDG CORP COM NEW
NOR
| $2.12M | ﹤0.01% |
101,974
+9,285
| +10% | +$208K |
|
1942
Terreno Realty
TRNO
$7.36B
| $2.12M | ﹤0.01% |
92,924
-25,381
| -21% | -$571K |
|
|
VIAB
1943
PUT
DELISTED
Viacom Inc. Class B
VIAB
| $2.12M | ﹤0.01% |
31,000
-320,300
| -91% | -$22.1M |
|
|
ZAGG
1944
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $2.11M | ﹤0.01% |
243,754
-61,248
| -20% | -$449K |
|
|
BID
1945
PUT
DELISTED
Sotheby's
BID
| $2.11M | ﹤0.01% |
50,000
-29,400
| -37% | -$1.25M |
|
|
RDUS
1946
DELISTED
Radius Recycling
RDUS
| $2.11M | ﹤0.01% |
+133,060
| New | +$2.24M |
|
1947
GoPro
GPRO
$110M
| $2.11M | ﹤0.01% |
48,587
+44,881
| +1,211% | +$2.12M |
|
|
CWEI
1948
DELISTED
Clayton Williams Energy, Inc.
CWEI
| $2.11M | ﹤0.01% |
41,652
+6,587
| +19% | +$363K |
|
1949
Jack Henry & Associates
JKHY
$12.2B
| $2.11M | ﹤0.01% |
30,142
-286
| -0.9% | -$18.7K |
|
1950
ePlus
PLUS
$2.25B
| $2.11M | ﹤0.01% |
96,928
+60,992
| +170% | +$1.19M |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.